News
Cantor Fitzgerald Reiterates Overweight on Akero Therapeutics
20 Jun 24
News, Reiteration, Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Akero Therapeutics
12 Jun 24
News, Reiteration, Analyst Ratings
Wolfe Research Initiates Coverage On Akero Therapeutics with Outperform Rating
11 Jun 24
News, Initiation, Analyst Ratings
Akero Therapeutics Begins Phase 3 Study on Efruxifermin for Liver Disease Treatment
11 Jun 24
News
HC Wainwright & Co. Reiterates Buy on Akero Therapeutics, Maintains $50 Price Target
11 Jun 24
News, Price Target, Reiteration, Analyst Ratings
Reported Saturday, Akero Therapeutics Presented Data Highlighting The Efficacy And Safety Of EFX In Patients With MASH At EASL Congress
10 Jun 24
News
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
5 Jun 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, Media, General
Evercore ISI Group Maintains Outperform on Akero Therapeutics, Lowers Price Target to $38
15 May 24
News, Price Target, Analyst Ratings
Canaccord Genuity Maintains Buy on Akero Therapeutics, Lowers Price Target to $56
13 May 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Akero Therapeutics, Maintains $50 Price Target
13 May 24
News, Price Target, Reiteration, Analyst Ratings
Akero Therapeutics Q1 EPS $(0.90) Beats $(0.95) Estimate
10 May 24
Earnings, Earnings Beats, News
Press releases
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – AKRO
20 Jun 24
News, Legal, Press Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
20 Jun 24
News, Legal, Press Releases
TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AKRO
20 Jun 24
News, Legal, Press Releases
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO
19 Jun 24
News, Legal, Press Releases
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. ("Akero") (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm
19 Jun 24
News, Legal, Press Releases
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
19 Jun 24
Press Releases
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
19 Jun 24
News, Legal, Press Releases
AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO
18 Jun 24
News, Legal, Press Releases
AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
18 Jun 24
Small Cap, Press Releases
AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
18 Jun 24
News, Legal, Press Releases
AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
18 Jun 24
Small Cap, Press Releases
Deadline in 7 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
18 Jun 24
News, Legal, Press Releases
Akero Therapeutics, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
17 Jun 24
News, Legal, Press Releases
Akero Therapeutics, Inc. Investors Reminder: A Securities Fraud Class Action Lawsuit Was Filed Against Akero Therapeutics, Inc. (AKRO) - Contact Kessler Topaz Meltzer & Check, LLP
17 Jun 24
Press Releases
DEADLINE ALERT for CMP, EXAI, AKRO, and MBUU: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
17 Jun 24
News, Legal, Press Releases
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
17 Jun 24
News, Legal, Press Releases
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. ("Akero") (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm
17 Jun 24
News, Legal, Press Releases
UPCOMING INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AKRO
17 Jun 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
15 Jun 24
Press Releases
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. - AKRO
14 Jun 24
Press Releases